glp 1 agonist and heart failure GLP-1 receptor agonist-based therapies cardiovascular risk: a review of mechanisms Results of cardiovascular outcomes trials
Description
Front Endocrinol (Lausanne) 2022;13:927859
About this article Cite this article Gonzales-Uribe, A., Ruiz-Cortez, R., Collantes-Silva, N
Shi K, Zhang G, Fu H, Li XM, Gao Y, Shi R, Xu HY, Li Y, Guo YK, Yang ZG
And they will say, I go to a restaurant, I have my hunger cues, but I'm satisfied with much less food than I used to eat before, and my body weight is maintained
Be mindful of any changes in mood, thoughts, or behaviors if you or someone you are caring for is taking this medication
